Tejara Capital LTD Roivant Sciences Ltd. Transaction History

Tejara Capital LTD

  • $153 Billion
  • Q4 2024

A detailed history of Tejara Capital LTD transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Tejara Capital LTD holds 813,550 shares of ROIV stock, worth $8.59 Million. This represents 6.3% of its overall portfolio holdings.

Number of Shares
813,550
Previous 1,420,990 42.75%
Holding current value
$8.59 Million
Previous $16.4 Billion 41.31%
% of portfolio
6.3%
Previous 7.81%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025
SELL
$11.16 - $12.71 $6.78 Million - $7.72 Million
-607,440 Reduced 42.75%
813,550 $9.62 Billion
Q3 2024

Nov 13, 2024
SELL
$10.17 - $12.5 $7.76 Million - $9.54 Million
-762,953 Reduced 34.93%
1,420,990 $16.4 Billion
Q2 2024

Aug 13, 2024
SELL
$10.36 - $11.74 $4.31 Million - $4.89 Million
-416,352 Reduced 16.01%
2,183,943 $23.1 Billion
Q1 2024

May 14, 2024
BUY
$9.87 - $11.8 $4.59 Million - $5.49 Million
465,400 Added 21.8%
2,600,295 $27.4 Billion
Q4 2023

Feb 12, 2024
BUY
$8.38 - $11.58 $14.9 Million - $20.6 Million
1,776,323 Added 495.39%
2,134,895 $24 Billion
Q3 2023

Nov 15, 2023
BUY
$9.76 - $13.19 $3.5 Million - $4.73 Million
358,572 New
358,572 $4.19 Billion
Q2 2023

Aug 11, 2023
BUY
$7.09 - $10.08 $130,888 - $186,086
18,461 Added 8.34%
239,907 $2.42 Billion
Q1 2023

May 12, 2023
BUY
$6.92 - $9.98 $1.53 Million - $2.21 Million
221,446 New
221,446 $1.63 Billion

Others Institutions Holding ROIV

# of Institutions
338
Shares Held
511M
Call Options Held
813K
Put Options Held
1.01M
View Full List

About Roivant Sciences Ltd.

ROIV Quotes by TradingView
  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $7.44B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Tejara Capital LTD Portfolio

Follow Tejara Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tejara Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tejara Capital LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email